Diabetic eye disease is one of the most frequently encountered conditions in a retina practice. Proper coding depends almost entirely on how clearly the diagnosis is documented in the chart for each encounter.

Many challenges in this area stem from misunderstandings about diabetic coding in ICD-10 and from insufficient specificity for the ocular manifestation in the chart. The following questions address common documentation gaps and how to prevent them.

Q: Must the type of diabetes be documented?

A: Yes. Because there are different causes and types of diabetes mellitus, the type is imperative to proper coding and thus must be documented in the chart. Documentation should not rely on demographic assumptions. The diabetes type must be explicitly stated in the chart. The following are the types, but they lack the additional characters for positions 4-7.

• E08 Diabetes mellitus due to underlying condition
• E09 Drug or chemical induced diabetes mellitus
• E10 Type 1 diabetes mellitus
• E11 Type 2 diabetes mellitus
• E13 Other specified diabetes mellitus

Q: What is the character placement and designation for an ophthalmic complication, and other associated conditions?

A: In each of the types of diabetes, there is an ophthalmic complication designated in the fourth character position with the number 3.

• E08.3 Diabetes mellitus due to underlying condition with ophthalmic complications
• E09.3 Drug- or chemical-induced diabetes mellitus with ophthalmic complications
• E10.3 Type 1 diabetes mellitus with ophthalmic complications
• E11.3 Type 2 diabetes mellitus with ophthalmic complications
• E13.3 Other specified diabetes mellitus with ophthalmic complications

The fifth character, severity, is designated with:

1 – unspecified diabetic retinopathy

2 – mild nonproliferative diabetic retinopathy

3 – moderate nonproliferative diabetic retinopathy

4 – severe nonproliferative diabetic retinopathy

5 – proliferative diabetic retinopathy

6 – diabetic cataract

7 – diabetic macular edema, resolved following treatment

9 – other diabetic ophthalmic complications

The sixth character, diabetic macular edema (DME), is designated with either:

1 – with macular edema

9 – without macular edema

The 7th character is laterality, designated with:

1 – right eye

2 – left eye

3 – bilateral

9 – unspecified eye

For example, combining the characters creates the highest specificity for the diagnosis code:

E11.3213 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral

Q: If “diabetic retinopathy” is documented in the chart, is that sufficient?

A: Not by itself, because the clinical picture includes more than the statement diabetic retinopathy (DR). ICD-10 coding requires the code to be at its highest specificity, which means the chart documentation should also include information such as:

• Diabetes type (Type 1, Type 2, drug-induced, other specified)
• Retinopathy severity (mild, moderate, severe nonproliferative DR, or proliferative DR)
• Presence or absence of macular edema
• Laterality

Without the appropriate elements, the diagnosis cannot be coded to its highest level of specificity.

Q: When is “diabetes without complications” appropriate?

A: Only when no diabetic complications are present. If there is an ocular manifestation, it must be documented in the chart and assigned the appropriate diagnosis code. Consistency between the assessment and the selected diagnosis is essential.

• E08.9 Diabetes due to underlying condition w/o complications
• E09.9 Drug- or chemical-induced diabetes mellitus w/o complications
• E10.9 Type 1 diabetes mellitus without complications
• E11.9 Type 2 diabetes mellitus without complications
• E13.9 Other specified diabetes mellitus without complications

Q: If imaging shows fluid but the assessment does not mention macular edema, can the chart support coding “with macular edema”?

A: No. Coding should be based on the physician’s documented diagnosis. Imaging findings alone do not justify a coded condition unless they are included in the assessment. If macular edema is clinically evident and impacts management, it must be documented in the assessment and plan.

Q: How specific does retinopathy severity documentation need to be?

A: Severity must be clearly stated as:

• Mild nonproliferative DR
• Moderate nonproliferative DR
• Severe nonproliferative DR
• Proliferative DR

General terms such as “diabetic retinopathy” or “stable DR” lack sufficient specificity to support accurate coding. Severity should reflect the clinical status at the time of the encounter.

Q: Should diabetes be coded separately from diabetic retinopathy?

A: No, because there is an ocular complication. Diabetic retinopathy codes are combination codes that include both the diabetes and the ocular complication. For example, proliferative DR with a tractional retinal detachment (TRD) involving the macula in the left eye in a Type 1 diabetic would be coded as E10.3522 – Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye.

Closing Thoughts

In retina practices, diabetic eye disease is managed over years and often decades. The documentation must be both consistent and accurate. When the chart clearly states the diabetes type, retinopathy stage, macular edema status, and laterality, coding becomes straightforward. When those elements are incomplete, unnecessary administrative risk increases. Accurate documentation of diagnoses supports compliant coding and reflects the complexity of the care being delivered. RP